contribution of CARD8, IL1B and IL18 in melanoma susceptibility and progression (W.C. Silva, T.M. Oshiro, D.C. Sá, D.D.G.S. Franco, C. Festa Neto, A. Pontillo, 2016) [2] . Data presented here refers to the distribution of selected inflammasome SNPs in a Brazilian case/control cohort. We have identified 4 inflammasome related Single Nucleotide Polymorphisms (SNPs) for CARD8 (rs6509365); IL1B (rs1143643) and IL18 (rs5744256 and rs1834481) related to melanoma susceptibility/protection. This data can serve as a potential prognostic marker in sporadic malignant melanoma.
& Published by Elsevier Inc.
Specifications Table   Subject Presence or absence of a particular polymorphism in inflammasome genes can drive an individual´s susceptibility to melanoma.
This dataset provides some selected inflammasome related SNPs' frequencies in a Brazilian case/ control melanoma cohort and its association with clinical outcomes.
Comparison of this dataset with other cohort dataset can help to elucidate the contribution of inflammasome genes in the development of and progression to sporadic malignant melanoma.
Data
A Brazilian case/control SMM cohort was studied concerning frequencies of selected inflammasome SNPs in NLRP1, NLRP3, CARD8, IL1B and IL18 genes and minor allele frequencies (MAF) with respective Hardy-Weinberg p-values were calculated.
Case/control analysis were performed and distribution of alleles for each selected SNP, as well as Odd Ratios (OR), haplotypes, Linkage disequilibrium analysis were determined.
Patients were stratified according to histological tumor type, invasiveness and skin type were represented (Fig. 1 ).
Experimental design, materials and methods
Refer to the associated article [2] for detailed methods (Table 1-5) .
